Foresite Capital Management IV, LLC's Net Worth
-$31.5 Million
Who is Foresite Capital Management IV, LLC?
Foresite Capital Management IV, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include 10x Genomics, Inc., Aclaris Therapeutics, Inc., AERIE PHARMACEUTICALS INC, and Kinnate Biopharma Inc..
SEC CIK
Foresite Capital Management IV, LLC's CIK is 0001704132
Past Insider Trading and Trends
2019 was Foresite Capital Management IV, LLC's most active year for acquiring shares with 22 total transactions. Foresite Capital Management IV, LLC's most active month to acquire stocks was the month of July. 2020 was Foresite Capital Management IV, LLC's most active year for disposing of shares, totalling 12 transactions. Foresite Capital Management IV, LLC's most active month to dispose stocks was the month of November. 2020 saw Foresite Capital Management IV, LLC paying a total of $20,000,000.00 for 10,838,311 shares, this is the most they've acquired in one year. In 2020 Foresite Capital Management IV, LLC cashed out on 10,837,137 shares for a total of $17,070,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
10x Genomics, Inc. (TXG) Snapshot price: $46.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aclaris Therapeutics, Inc. (ACRS) Snapshot price: $1.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -99.58% | -1.95M |
—
|
—
| 8.28K |
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AERIE PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -18.10% | -1.00M |
$17.07 | -$17,070,000.00 | 4.52M |
Feb 27
| |||
Form 4
| +1.96% | 28.9K |
$30.00 | $867,000.00 | 1.5M |
Dec 20
| |||
Form 4
| +2.15% | 31K |
$30.00 | $930,000.00 | 1.47M |
Nov 26 - Dec 3
| |||
Form 4
| +1.81% | 25.6K |
$30.00 | $768,000.00 | 1.44M |
Nov 14 - Nov 15
| |||
Form 4
| +1.07% | 15K |
$30.00 | $450,000.00 | 1.42M |
Nov 7
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +1.94% | 115.9K |
$18.46 | $2,140,890.00 | 6.09M |
Sep 4 - Sep 5
| |||
Form 4
| +3.33% | 75K |
$21.00 | $1,574,741.00 | 2.33M |
Aug 30 - Sep 3
| |||
Form 4
| +2.09% | 46.15K |
$23.45 | $1,082,449.25 | 2.25M |
Aug 21 - Aug 23
| |||
Form 4
| +7.50% | 153.85K |
$23.88 | $3,673,288.98 | 2.2M |
Aug 16 - Aug 20
| |||
Form 4
| +19.13% | 539.55K |
$24.34 | $13,341,170.45 | 3.36M |
Aug 12 - Aug 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kinnate Biopharma Inc. (KNTE) Snapshot price: $2.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -13.72M |
—
|
—
|
0
|
Apr 3
| |||
Form 4
| +78.53% | 1.78M |
$2.80 | $4,984,000.00 | 4.05M |
May 8
| |||
Form 4
| +125.71% | 1.1M |
—
|
—
| 1.98M |
Feb 17
| |||
Form 4
| +983.83% | 9.84M |
—
|
—
| 10.84M |
Dec 7
| |||
Form 4
|
∞
| 1M |
$20.00 | $20,000,000.00 | 1M |
Dec 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||